Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
05/2003
05/30/2003WO2003043973A2 Amine phenolic compounds and their use as hardeners and/or accelerators in epoxy coatings
05/30/2003WO2003043625A1 2-aryl-propionic acids and pharmaceutical compositions containing them
05/30/2003WO2003043624A1 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/29/2003US20030100790 Such as N-formyl-D,L-alanine methyl ester by reacting butyl formate with alanine; by product inhibition
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030098243 Process for the preparation of 5-aminosalicyclic acid
05/28/2003EP1314777A1 Pro-perfume compositions used in cleaning or fabric treatment products
05/28/2003EP1314716A1 Amine phenolic compounds and their use as hardener and/or accelerators in epoxy coatings
05/28/2003EP1313695A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/28/2003EP1313694A1 Process for making n-aryl-anthranilic acids and their derivatives
05/28/2003EP1313560A1 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION
05/28/2003EP0736019B1 1,3-oxazin-4-one derivatives, process and intermediates for their preparation and their use as herbicides
05/28/2003CN1420866A Process for preparation of 7-azabicyclo ÒÇö4.1.0ÒÇò-hept-3-ene-3-carboxylic acid esters
05/28/2003CN1420862A Method for synthesis of N-ÒÇö(S)-1-carboxybutylÒÇò-(S)- alanine esters and use in synthesis of perindopril
05/28/2003CN1109670C Process for preparing halosubstd. aromatic acid
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6569899 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/27/2003US6569829 Removing impurities from a long chain N-acyl acidic amino acid such as N-lauroyl-L-glutamic acid containing an inorganic salt by solvent extraction using a solution of water and tert-butanol; use in cosmetics and detergents
05/27/2003US6569411 Deodoring, microbiocides, marking odors
05/22/2003WO2003042169A2 Process for synthesizing aspartic and glutamic acid derivatives and diazoketone intermediates thereof
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042163A1 N-methyl-homocystines, use thereof and method for the production thereof
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042136A2 Process for the production of l-dopa ethyl ester
05/22/2003WO2003041646A2 L-dopa ethyl ester salts and uses thereof
05/22/2003WO2002095393A3 Drug evolution: drug design at hot spots
05/22/2003WO2002044144A3 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
05/22/2003US20030097020 Process for the preparation of carboxylic acid salts from primary alcohols
05/22/2003US20030097019 T-butyl cascade polymers
05/22/2003US20030097005 Method for the preparation of enantiomerically enriched compounds
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003CA2467264A1 N-methyl-homocystines, use thereof and method for the production thereof
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/21/2003EP1312611A1 Method of continuously degrading protein
05/21/2003EP1311480A1 New amidino derivatives and their use as thrombin inhibitors
05/21/2003EP0902011B1 Gamma-oxo-homophenylalanine derivatives and process for producing homophenylalanine derivatives by reducing the same
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1418863A Process for producing m-dimethylamine benzoic acid
05/21/2003CN1418862A Method for preparing dextrorotary phenylalanine by asymmetric conversion method
05/20/2003US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis
05/20/2003US6566552 Reduction of an alkyl 4-chloro-3 -oxobutyrate or -oxobutyr amide to 4-chloro-3 -hydroxybutyrate or -hydroxybutyramide in the presence of ruthenium complex reduction catalyst followed by quaternization with trimethylamine
05/20/2003US6566550 Substituted aromatic ethers as inhibitors of glycine transport
05/20/2003US6566547 Fungicides
05/20/2003US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers
05/20/2003US6566330 Positively charged non-natural amino acids, methods of making and using thereof in peptides
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040439A2 A process for crystallising oxonorleucinacetal
05/15/2003WO2003040085A1 Process for producing aminohydroxyaromatic carboxylic acid and/or derivative thereof
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003US20030092933 Dehydrating gabapentin monohydrate to form crystalline gabapentin dehydrate Form A, allowing dehydrate A to stand at ambient temperatures to form crystalline gabapentin dehydrate Form B
05/15/2003US20030092769 Diaryl-enynes
05/14/2003EP1310481A1 Process for the preparation of N-formyl-aminocarboxylic acid esters
05/14/2003EP1309653A1 Polymeric methine ultraviolet absorbers
05/14/2003EP1309562A1 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
05/14/2003EP1309541A1 Hydrolysis of acylamino acids
05/14/2003EP1137399B1 Improvements in or relating to powders
05/14/2003CN1417202A Preparation process of N-formamido carboxylic ester
05/13/2003US6562989 Catalyst for aromatic C—O, C—N, and C—C bond formation
05/13/2003US6562977 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003US6562815 Morpholinones as light stabilizers
05/13/2003US6562608 Coenzymes useful for the synthesis of L-carnitine
05/13/2003CA2107276C Mineral oil middle distillate compositions
05/08/2003WO2003037846A1 Production of keto acids
05/08/2003WO2002076928A3 Alkylamine derivatives as antifouling agents
05/08/2003WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
05/08/2003WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/08/2003US20030088122 Method of preparing amino carboxylic acids
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003CA2463156A1 Production of keto acids
05/07/2003EP1308436A1 Calcium receptor antagonists
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP1015415B1 Novel stereoselective processes for the preparation of gabapentin analogues
05/07/2003CN1415598A Method for industrialized synthesizing 3,5 diamido-4-chlorobenzoic acid isobutyl alcohl
05/07/2003CN1107668C Process for preparing alpha, omega, delta-tribenzyloxycarbonyl arginine
05/06/2003US6559274 Stabilized monoaspartic acid esters and polyaspartic acid esters
05/02/2003EP1305325A1 Method for preparing a chromium iii organic complex, its use as corrosion inhibiting agent and as anticorrosive coating agent
05/02/2003EP1305281A1 Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof
05/02/2003EP1121351A4 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
05/01/2003WO2002026701A3 Ionic liquids and their use as solvents
05/01/2003US20030083520 Process for preparing bicyclic amino acid
05/01/2003US20030083505 Benzenedicarboxylic acid derivatives
05/01/2003US20030083502 Preparation of 4-haloalkylnicotinic esters
05/01/2003US20030083384 Formed via chemical reduction and hydrolysis with minimal use of halogenated solvents; comprises use of intermediates such as ethyl 2-benzylideneamino-2-difluoromethyl-4-cyanobutanoate
05/01/2003US20030083348 Farnesyl transferase inhibitors
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030083269 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment
05/01/2003US20030082831 Apparatus for use in the synthesis of preferential biopolymers
05/01/2003US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science
04/2003
04/30/2003CN1414948A Process for preparing alkylene diamine triacetic acid
04/29/2003US6555706 Process for making iminodiacetic acid compounds from monoethanolamine substrates
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/24/2003WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them